Stay updated with breaking news from Patient Support Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
KEYTRUDA is the first and only anti-PD-1 therapy approved in combination with chemoradiotherapy for these patients Approval marks third FDA-approved indication for KEYTRUDA in cervical cancer and...
The U.S. government is winding down control of the COVID-19 therapeutics distribution and moving towards commercialization, much like with vaccines earlier in the fall. The Administration for Strategic Preparedness and Response developed this resource outlining the transition plan. Merck and Pfizer are releasing additional information as well.
The U.S. government is winding down control of the COVID-19 therapeutics distribution and moving towards commercialization, much like with vaccines earlier in the fall. The Administration for Strategic Preparedness and Response developed this resource outlining the transition plan. Merck and Pfizer are releasing additional information as well.
There is evidence to show patient support programs have been used to encourage use of a company’s drug, which is problematic, doctors say